Avg Down | NAVB Message Board Posts

Navidea Biopharmaceuticals, Inc.

  NAVB website


    30% off entry-level Bronze Patron packages (retails for $250 - reduced to $175)
    includes 2 yrs of Premium Plus service & locks in 30% discount for any future Patron upgrades

    Only 35 spots available (first come, first served)

    BONUS: Purchase your spot over the next 24 hrs & get an extra year of Premium Plus service absolutely free! 

    CLICK HERE to become a Bronze Patron now 

NAVB   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  30102 of 31504  at  6/19/2019 1:49:23 PM  by


 In response to msg 30100 by  TurboTime
view thread

Re: Avg Down

  Okay, I understand, but your points tend to suggest a plan for a long term position, not a 'run up' and sell strategy.
If, as you put it, the RA Phase II data proves the tc99m backbone for other diagnostics, and for therapy, then that would open a floodgate of partners and be reason for a long term position, not a run up and sell strategy.
Like I have said many times before, if the tc99m was really proven for the indications given, big pharma would be all over this little company like stink on shit. Again, that's a strategy for a long term position, though.
I guess what I am saying is that if you are correct about the RA trail proving the theory behind tc99m,  why would you want to sell?

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 244
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
Financial Market Data provided by